Intracellular Mechanisms of TRAIL and Its Role in Cancer Therapy

This publication has 82 references indexed in Scilit:

• Bcl-2–Mediated Drug Resistance
  The Journal of Experimental Medicine, 1999
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II
  Cell, 1999
• The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
  Immunity, 1997
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
  Science, 1997
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
  Journal of Biological Chemistry, 1996
• Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
  Nature, 1996
• Identification and characterization of a new member of the TNF family that induces apoptosis
  Immunity, 1995
• CrmA, a Poxvirus-encoded Serpin, Inhibits Cytotoxic T-lymphocyte-mediated Apoptosis
  Published by Elsevier ,1995
• CrmA-inhibitable Cleavage of the 70-kDa Protein Component of the U1 Small Nuclear Ribonucleoprotein during Fas- and Tumor Necrosis Factor-induced Apoptosis
  Published by Elsevier ,1995